Quantifying intervention-related improvements in exercise tolerance

European Respiratory Journal

Volumn 33, Issue 6, 2009, Pages 1254-1260

  Whipp, B J ^a   Ward, S A ^a  

^a Human Bio Energetics Research Centre   (United Kingdom)

Author keywords

Critical power; Endurance test; Power duration relationship; Therapeutic intervention; Tolerance time

Indexed keywords

LACTIC ACID; OXITROPIUM BROMIDE; OXYGEN;

BICYCLE ERGOMETRY; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; CLINICAL PROTOCOL; ENDURANCE; EXERCISE TOLERANCE; LUNG DISEASE; LUNG GAS EXCHANGE; LUNG VENTILATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANGE OF MOTION; REPRODUCIBILITY; REVIEW;

EXERCISE TEST; EXERCISE TOLERANCE; HUMANS; OXYGEN CONSUMPTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPRODUCIBILITY OF RESULTS; SOCIETIES, MEDICAL;

EID: 69249098528     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00110108     Document Type: Review

References (64)

1. American Thoracic Society, American College of Chest Physicians. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003; 167: 211-277.
2. Palange P, Ward SA, Carlsen K-H, et al. Recommendations on the use of exercise testing in clinical practice. Eur Resp J 2007; 29: 185-209.
3. Casaburi R. Factors determining constant work rate exercise tolerance in COPD and their role in dictating the minimal clinically important difference in response to interventions. COPD 2005; 2: 131-136.
4. O'Donnell DE, Voduc N, Fitzpatrick M, et al. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J 2004; 24: 86-94.
5. Palange P, Valli G, Onorati P, et al. Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients. J Appl Physiol 2004; 97: 1637-1642.
6. van't Hul A, Gosselink R, Hollander P, et al. Training with inspiratory pressure support in patients with severe COPD. Eur Respir J 2006; 27: 65-72.
7. Oga T, Nishimura K, Tsukino M, et al. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests. Am J Respir Crit Care Med 2000; 161: 1897-1901.
8. Porszasz J, Emtner M, Goto S, et al. Exercise training decreases ventilatory requirements and exercise-induced hyperinflation at submaximal intensities in patients with COPD. Chest 2005; 128: 2025-2034.
9. Poole DP, Ward SA, Whipp BJ. Effect of training on the metabolic and respiratory profile of heavy and severe exercise. Eur J Appl Physiol 1990; 59: 421-429.
10. Ortega F, Toral J, Cejudo P, et al. Comparison of effects of strength and endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166: 669-674.
11. Neder JA, Sword D, Ward SA, et al. Home based neuromuscular electrical stimulation as a new rehabilitative strategy for severely disabled patients with chronic obstructive pulmonary disease (COPD). Thorax 2002; 57: 333-337.
12. Costes F, Agresti A, Court-Fortune I, et al. Noninvasive ventilation during exercise training improves exercise tolerance in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2003; 23: 307-313.
13. Emtner M, Porszasz J, Burns M, et al. Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. Am J Respir Crit Care Med 2003; 168: 1034-1042.
14. Whipp BJ. The bioenergetic and gas-exchange basis of exercise testing. Clin Chest Med 1994; 15: 173-192.
15. Morton RH, Green S, Bishop D, et al. Ramp and constant power trials produce equivalent critical power estimates. Med Sci Sports Exerc 1997; 29: 833-836.
16. Davis JA, Whipp BJ, Huntsman DJ, et al. Criteria for establishing the slope of ramp work rate exercise tests. Med Sci Sports 1982; 14: 339-343.
17. Hansen JE, Sue DY, Oren A, et al. Relation of oxygen uptake to work rate in normal men and men with circulatory disorders. Am J Cardiol 1987; 59: 669-674.
18. Taylor HL, Buskirk E, Henschel A. Maximal oxygen intake as an objective measure of cardiorespiratory performance. J Appl Physiol 1955; 8: 73-80.
19. Mitchell JH, Sproule BJ, Chapman CB. The physiological meaning of the maximal oxygen intake test. J Clin Invest 1957; 37: 538-547.
20. Scheuermann BW, Kowalchuk JM. Attenuated respiratory compensation during rapidly incremented ramp exercise. Respir Physiol 1998; 114: 227-238.
21. Neder JA, Jones PW, Nery LE, et al. Determinants of the exercise endurance capacity in patients with chronic obstructive pulmonary disease. The power-duration relationship. Am J Respir Crit Care Med 2000; 162: 497-504.
22. Casas A, Vilaro J, Rabinovich R, et al. Encouraged 6-min walking test indicates maximum sustainable exercise in COPD patients. Chest 2005; 128: 55-61.
23. Saey D, Debigare R, LeBlanc P, et al. Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 168: 425-430.
24. Killian KJ, LeBlanc P, Martin DH, et al. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with airflow limitation. Am Rev Respir Dis 1992; 146: 935-940.
25. Wasserman K, Hansen JE, Sue DY, et al. Principles of Exercise Testing and Interpretation. 4th Edn. Philadelphia, Lea & Febiger, 2005.
26. Cooper CB, Storer TW. Exercise Testing and Interpretation. Cambridge, Cambridge University Press, 2001.
27. Whipp BJ, Ward SA. Physiological determinants of pulmonary gas exchange kinetics during exercise. Med Sci Sports Ex 1990; 22: 62-71.
28. Linnarsson D. Dynamics of pulmonary gas exchange and heart rate changes at start and end of exercise. Acta Physiol Scand 1974; 415: Suppl., 1-68.
29. 2 uptake during exercise: conflating muscular and cardiovascular responses. Med Sci Sports Exerc 2005; 37: 1574-1585.
30. 2 kinetics during heavy exercise. Med Sci Sports Exerc 1994; 26: 1327-1334.
31. Jones AM, Poole DC. Oxygen uptake dynamics: from muscle to mouth - an introduction to the symposium. Med Sci Sports Exerc 2005; 37: 1542-1550.
32. Whipp BJ, Rossiter HB, Ward SA. Exertional oxygen uptake kinetics: a stamen of stamina? Biochem Trans 2002; 30: 237-247.
33. Hansen JE, Sue DY, Wasserman K. Predicted values for clinical exercise testing. Am Rev Respir Dis 1984; 129: Suppl, S49-S55.
34. Hogan MC, Gladden LB, Kurdak SS, et al. Increased [lactate] in working dog muscle reduces tension development independent of pH. Med Sci Sports Exerc 1995; 27: 371-377.
35. 2+-channel activity from skeletal muscle sarcoplasmic reticulum. J Appl Physiol 1997; 82: 447-452.
36. Fitts RH. Cellular mechanisms of muscle fatigue. Physiol Rev 1994; 74: 49-94.
37. Westerblad H, Allen DG, Lännergren J. Muscle fatigue: lactic acid or inorganic phosphate the major cause? News Physiol Sci 2002; 17: 17-21.
38. Monod H, Scherrer J. The work capacity of a synergic muscular group. Ergonomics 1965; 8: 329-338.
39. Poole DC, Ward SA, Gardner GW, et al. Metabolic and respiratory profile of the upper limit for prolonged exercise in man. Ergonomics 1988; 31: 1265-1279.
40. Hughson RL, Orok CK, Staudt LE. A high velocity treadmill running test to assess endurance running potential. Int J Sports Med 1984; 5: 23-25.
41. Hill DW. The critical power concept: a review. Sports Med 1993; 16: 237-254.
42. Wakayoshi K, Ikuta K, Yoshida T, et al. Determination and validity of critical velocity as an index of swimming performance in the competitive athlete. Europ J Appl Physiol 1992; 64: 153-157.
43. Nakamura FY, Borges TO, Sales OR, et al. Energetic cost estimation and contribution of different metabolic pathways in speed kayaking. Rev Bras Med Esporte 2004; 10: 78-84.
44. Whipp BJ. Domains of aerobic function and their limiting parameters. In: Steinacker JM, Ward SA, eds. The Physiology and Pathophysiology of Exercise Tolerance. New York, Plenum, 1996; pp. 83-89.
45. Jones AM, Wilkerson DP, DiMenna F, et al. Muscle metabolic responses to exercise above and below the "critical power" assessed using 31P-MRS. Am J Physiol Regul Integr Comp Physiol 2008; 294: R585-R593.
46. Puente-Maestu L, Santa Cruz A, Vargas T, et al. Effects of training on the tolerance to high-intensity exercise in patients with severe COPD. Respiration 2003; 70: 367-370.
47. Gaesser GA, Wilson LA. Effects of continuous and interval training on the parameters of the power-endurance time relationship for high-intensity exercise. Int J Sports Med 1988; 9: 417-421.
48. Poole DP, Ward SA, Whipp BJ. Effect of training on the metabolic and respiratory profile of heavy and severe exercise. Eur J Appl Physiol 1990; 59: 421-429.
49. Jenkins DG, Quigley BM. The influence of high-intensity exercise training on the Wlim-Tlim relationship. Med Sci Sports Exerc 1993; 25: 275-282.
50. Miura A, Endo M, Sato H, et al. Relationship between the curvature constant parameter of the power-duration curve and muscle cross-sectional area of the thigh for cycle ergometry in humans. Eur J Appl Physiol 2002; 87: 238-244.
51. Moritani T, Nagata A, de Vries HA, et al. Critical power as a measure of physical work capacity and anaerobic threshold. Ergonomics 1981; 24: 339-350.
52. Whipp BJ, Huntsman DJ, Storer TW, et al. A constant which determines the duration of tolerance to high-intensity work. Fed Proc 1982; 41: 1591.
53. Miura A, Kino F, Kajitani S, et al. The effect of oral creatine supplementation on the curvature constant parameter of the power-duration curve for cycle ergometry in humans. Jpn J Physiol 1999; 49: 169-174.
54. Miura A, Sato H, Sato H, et al. The effect of glycogen depletion on the curvature constant parameter of the power-duration curve for cycle ergometry. Ergonomics 2000; 43: 133-141.
55. Nebelsick-Gullett LJ, Housh TJ, Johnson GO, et al. A comparison between methods of measuring anaerobic work capacity. Ergonomics 1988; 31: 1413-1419.
56. Noseda A, Carpiaux JP, Prigogine T, et al. Lung function, maximum and submaximum exercise testing in COPD patients: reproducibility over a long interval. Lung 1989; 167: 247-257.
57. O'Donnell DE, Lam M, Webb KA. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 1557-1565.
58. van't Hul A, Gosselink R, Kwakkel G. Constant-load cycle endurance performance: test-retest reliability and validity in patients with COPD. J Cardiopulm Rehabil 2003; 23: 143-150.
59. Casaburi R, Kukafka D, Cooper CB, et al. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest 2005; 127: 809-817.
60. Lapicque L. Définition expérimentale de l'excitabilité [Experimental definition of exitability]. Soc Biol 1909; 77: 280-283.
61. Holsheimer J, Dijkstra EA, Demeulemeester H, et al. Chronaxie calculated from current-duration and voltage-duration data. J Neurosci Methods 2000; 97: 45-50.
62. Brickley G, Dekerle J, Hammond AJ, et al. Assessment of maximal aerobic power and critical power in a single 90-s isokinetic all-out cycling test. Int J Sports Med 2007; 28: 414-419.
63. Vanhatalo A, Doust JH, Burnley M. Determination of critical power using a 3-min all-out cycling test. Med Sci Sports Exerc 2007; 39: 548-555.
64. Malaguti C, Nery LE, Dal Corso S, et al. Alternative strategies for exercise critical power estimation in patients with COPD. Eur J Appl Physiol 2006; 96: 59-65.